benchmark
metric
relat
laboratori
test
util
base
evidencebas
medic
literatur
may
suffer
posit
public
bia
guidelin
good
data
review
creat
disrupt
technolog
requir
time
appropri
use
establish
util
review
meaning
metric
includ
monitor
use
obsolet
test
inappropri
use
lab
test
test
util
client
hospit
outreach
program
use
monitor
impact
new
client
lab
workload
multidisciplinari
laboratori
util
committe
effect
tool
modifi
bad
habit
review
approv
new
test
lab
formulari
send
refer
lab
laboratori
test
overutil
estim
repres
laboratori
test
intern
effort
made
reduc
demand
util
util
test
effici
outcom
involv
format
laboratori
util
committe
laboratori
formulari
committe
base
hospit
pharmaci
therapeut
committe
organiz
structur
committe
evalu
clinic
valu
laboratori
test
use
evidencebas
review
appropri
medic
literatur
literatur
review
numer
profession
specialti
medic
organ
well
healthcar
insur
carrier
determin
test
procedur
perform
reimburs
conclus
base
review
need
updat
regular
basi
qualiti
guidelin
good
publish
studi
base
often
relev
studi
evalu
laboratori
test
demonstr
neg
find
publish
phenomenon
refer
posit
public
bia
public
bia
tzoulaki
et
al
demonstr
public
bia
review
report
evalu
emerg
cardiovascular
biomark
therefor
misinterpret
potenti
impact
fail
publish
studi
neg
result
review
evidencebas
literatur
reader
bewar
test
may
obsolet
retir
clinic
use
other
may
inappropri
use
specif
diseas
categori
play
field
level
least
six
newer
gamechang
disrupt
technolog
evalu
result
modif
clinic
practic
laboratori
test
modal
newer
disrupt
technolog
may
replac
obsolet
inappropri
test
lab
util
benchmark
metric
continu
flux
consequ
case
evolv
newer
technolog
imper
explor
impact
earli
develop
anticip
monitor
impact
laboratori
test
three
author
review
current
literatur
relat
laboratori
test
util
emphasi
definit
obsolet
inappropri
test
util
origin
evalu
whole
genom
sequenc
next
gener
sequenc
proteom
exampl
high
impact
disrupt
technolog
gener
larg
quantiti
data
need
softwar
reduc
clinic
use
result
practic
exampl
obsolet
inappropri
test
review
potenti
metric
monitor
improv
test
util
anoth
use
metric
test
util
client
hospit
outreach
program
use
monitor
impact
new
client
laboratori
workload
final
result
publish
data
work
laboratori
util
committe
summar
benchmark
metric
laboratori
util
review
three
disrupt
technolog
well
obsolet
inappropri
use
test
medic
practic
well
patholog
midst
rapid
develop
least
six
major
gamechang
disrupt
technolog
includ
genet
proteom
digit
patholog
informat
therapeut
patholog
vivo
diagnost
six
disrupt
technolog
share
similar
issu
like
resolut
best
applic
routin
clinic
use
pauciti
evidencebas
outcom
literatur
review
educ
practition
physician
user
clinic
inform
gener
softwar
convert
big
databas
method
gener
clinic
use
inform
util
techniqu
increas
barrier
obstacl
clinic
use
overcom
exampl
disrupt
technolog
next
gener
sequenc
massiv
parallel
sequenc
techniqu
current
clear
us
food
drug
administr
use
gener
genom
wide
sequenc
one
author
flk
genom
sequenc
clia
approv
laboratori
illumina
san
diego
ca
result
reveal
million
variant
compar
refer
method
variant
exom
code
element
studi
interrog
gene
causal
associ
condit
recommend
american
colleg
medic
genet
limit
number
gene
variant
detect
classifi
clinic
signific
carrier
statu
variant
unknown
signific
like
benign
variant
benign
variant
definit
variant
call
failur
techniqu
detect
delet
insert
interspers
repeat
tandem
repeat
repeat
adjac
like
triplet
repeat
may
lead
inappropri
interpret
result
expens
follow
clinic
laboratori
evalu
exampl
clinic
signific
pathogen
variant
report
least
unrel
case
control
data
may
found
addit
genom
studi
popul
benign
variant
also
found
new
variant
contain
mutat
lead
signific
deleteri
effect
gene
function
softwar
applic
variant
signific
assign
like
datagenno
need
uptod
latest
genotypephenotyp
associ
prevent
fals
posit
find
inappropri
followup
test
highest
rate
report
cancer
prostat
lung
bronchu
colon
rectum
men
femal
breast
replac
prostat
women
us
annual
incid
rate
case
per
individu
comprehens
sequenc
numer
human
cancer
reveal
driver
gene
gene
per
tumor
alter
intracellular
signal
transduct
pathway
relat
cell
futur
death
surviv
andor
genom
mainten
least
fda
approv
cancer
therapi
base
inhibit
tumoractiv
intracellular
pathway
exampl
braf
kinas
inhibitor
vemurafenib
shown
respons
rate
patient
metastat
melanoma
braf
valin
glutam
acid
mutat
codon
mutat
associ
aggress
clinic
cours
patient
thyroid
papillari
microcarcinoma
one
studi
hybrid
score
compos
one
molecular
diagnost
histopatholog
paramet
use
predict
tumor
clinic
cours
sensit
specif
select
correct
molecular
diagnost
test
specif
tumor
aid
publish
guidelin
immunohistochemistri
detect
estrogen
progesteron
receptor
breast
cancer
american
societi
clinic
oncolog
colleg
american
pathologist
select
lung
cancer
patient
egfr
alk
tyrosin
kinas
inhibitor
intern
associ
studi
lung
cancer
associ
molecular
patholog
colleg
american
pathologist
whole
genom
sequenc
tumor
provid
access
known
unknown
variant
relat
tumor
surviv
skill
develop
softwar
convert
patient
raw
genom
sequenc
medic
relev
assess
therapeut
target
drug
metabol
base
tumor
bodi
site
use
genom
analysi
clinician
want
know
anticanc
drug
drug
patient
respond
well
dose
malditof
matrix
assist
laser
desorpt
ionizationtim
flight
spectroscopi
rel
new
technolog
clinic
microbiolog
laboratori
pathogen
identif
alway
reli
visual
biochem
interrog
summari
result
may
point
specif
identif
genu
speci
sometim
least
genu
level
visual
biochem
result
sometim
yield
variabl
result
mean
case
id
may
chang
depend
result
use
malditof
allow
clinic
microbiolog
laboratori
identifi
bacteria
isol
cultur
potenti
without
perform
biochem
test
implic
quicker
pathogen
identif
clinician
potenti
affect
antibiot
treatment
suscept
result
avail
abil
obtain
quicker
answer
disrupt
test
workflow
requir
reevalu
workflow
optim
use
malditof
antibiot
suscept
test
benchmark
subsequ
metric
monitor
laboratori
test
util
develop
profession
subspecialti
medic
organ
format
recommend
guidelin
exampl
includ
guidelin
hypothyroid
adult
american
associ
clinic
endocrinologist
american
thyroid
associ
definit
myocardi
infarct
american
colleg
cardiolog
foundat
american
heart
associ
definit
diabet
mellitu
american
diabet
associ
pharmacogenet
well
followup
test
metabol
diseas
identifi
expand
newborn
screen
use
tandem
mass
spectrometri
nation
academi
clinic
biochemistri
use
bone
metabol
marker
japan
osteoporosi
societi
thirtyf
specialti
societi
join
choos
wise
project
organ
american
board
intern
medicin
societi
ask
provid
five
specif
evidencebas
recommend
test
procedur
may
appropri
inappropri
patient
care
wwwchoosingwiselyorg
review
list
specialti
societi
reveal
recommend
laboratori
test
referenc
item
total
one
organ
american
societi
clinic
patholog
list
laboratori
testrel
recommend
kale
et
al
review
nation
annual
save
outpati
visit
primari
care
physician
includ
unnecessari
inappropri
laboratori
test
includ
cbc
million
urinalysi
million
basic
metabol
panel
million
three
procedur
yield
annual
cost
save
million
compar
elimin
inappropri
pap
test
annual
save
million
figur
illustr
magnitud
healthcar
save
implement
simpl
laboratori
test
order
practic
reduc
duplic
andor
inappropri
test
collabor
subspecialti
medic
societi
disrupt
technolog
develop
improv
routin
clinic
laboratori
test
util
fertil
area
develop
benchmark
metric
futur
laboratori
test
util
appropri
laboratori
test
appropri
util
laboratori
test
alway
import
patient
care
requir
increas
scrutini
era
contain
healthcar
cost
object
criteria
judg
appropri
test
util
univers
develop
appli
alway
easi
defin
term
insur
compani
recogn
medic
financi
burden
unnecessari
test
take
action
mani
compani
post
inform
websit
defin
obsolet
unreli
lab
test
readili
access
internet
includ
aetna
unit
healthcar
amerihealth
one
criterion
judg
appropri
test
determin
obsolet
definit
obsolet
note
merriamwebst
onlin
dictionari
http
wwwmerriamwebst
comdictionari
longer
use
longer
use
synonym
includ
antiqu
archaic
date
demod
fossil
kaput
time
advanc
medic
technolog
laboratori
test
becom
outdat
although
difficult
remov
test
laboratori
formulari
good
reason
reason
includ
avail
sensit
specif
accur
test
new
guidelin
recommend
elimin
test
replac
anoth
test
clinic
patholog
must
consid
obsolesc
includ
uptak
lactic
acid
dehydrogenas
ldh
isoenzym
clinic
chemistri
lab
bleed
time
hematolog
obsolet
test
microbiolog
laboratori
includ
bacteri
antigen
detect
test
group
b
streptococcu
antigen
gb
test
western
blot
uptak
free
thyroxin
index
fti
still
order
physician
despit
fact
altern
test
avail
mani
year
uptak
old
test
design
purpos
indirectli
measur
free
thyroxin
develop
avail
direct
assay
abl
accur
measur
free
level
standard
free
assay
report
use
timeconsum
equilibrium
dialysi
combin
isotop
dilutionliquid
chromatographytandem
mass
spectrometri
uptak
assess
unsatur
unbound
thyroxin
thyroid
bind
protein
serum
use
total
calcul
fti
fti
obtain
multipli
total
time
updat
longer
need
estim
free
assay
direct
measur
free
everi
laboratori
support
evid
obsolesc
updat
fti
avail
decad
current
guidelin
diagnosi
manag
hypothyroid
hyperthyroid
thyroid
diseas
pregnanc
longer
includ
assess
updat
fti
analysi
lactic
acid
dehydrogenas
ldh
isoenzym
electrophoresi
util
aid
diagnosi
myocardi
infarct
develop
specif
test
myocardi
damag
troponin
littl
use
insensit
timeconsum
electrophoret
assay
current
guidelin
clearli
establish
prefer
marker
cardiac
injuri
troponin
bleed
time
crude
test
hemostasi
arrest
stoppag
bleed
indic
well
platelet
interact
blood
vessel
wall
form
blood
clot
indirectli
assess
platelet
function
perform
make
small
incis
skin
measur
second
time
taken
bleed
stop
test
design
assess
platelet
function
exclud
von
willebrand
diseas
test
labor
intens
invas
poorli
reproduc
insensit
histor
perform
screen
test
higher
sensit
platelet
dysfunct
von
willebrand
diseas
vwd
unavail
bleed
time
replac
instrument
assess
platelet
function
whole
blood
aggreg
studi
avail
instrument
includ
platelet
function
analyz
siemen
usa
verifynow
accumetr
plateletwork
helena
impact
diam
thromboelastograph
teg
haemonet
initi
test
bleed
disord
rule
common
caus
bleed
test
includ
complet
blood
platelet
count
ptt
pt
possibl
fibrinogen
level
thrombin
time
addit
test
von
willebrand
diseas
vwf
antigen
ristocetin
cofactor
activ
factor
viii
clot
activ
confirm
diseas
bacteri
antigen
detect
test
consid
obsolet
histor
use
adjunct
laboratori
test
diagnosi
bacteri
mening
test
purport
advantag
rapid
detect
h
influenza
n
meningitid
pneumonia
agalactia
overal
sensit
essenti
gramstain
smear
cytocentrifug
csf
specimen
advent
vaccin
h
influenza
type
b
n
meningitid
c
antigen
test
even
less
use
literatur
confirm
use
direct
antigen
test
csf
neither
sensit
specif
importantli
gram
stain
cultur
still
need
perform
regardless
initi
antigen
test
result
base
data
review
laboratori
discontinu
test
inhous
exampl
test
remov
market
base
recommend
center
diseas
control
cdc
state
rapid
antigen
detect
test
gb
sensit
enough
replac
cultur
base
prenat
screen
use
place
riskbas
approach
cultur
result
unknown
time
labor
poor
perform
rapid
antigen
test
cdc
recommend
intrapartum
chemoprophylaxi
antibiot
administ
women
certain
risk
factor
laboratori
look
intern
data
patient
popul
found
sensit
rapid
antigen
test
use
fortyon
patient
miss
rapid
antigen
test
detect
cultur
data
literatur
show
averag
sensit
among
variou
lab
survey
exampl
cdc
recommend
assess
test
perform
within
laboratori
support
move
test
obsolesc
western
blot
wb
constant
one
confirmatori
test
hiv
antibodi
test
howev
wb
move
way
obsolesc
newer
gener
antigenantibodi
molecular
assay
becom
part
new
hiv
test
algorithm
wb
alway
issu
indetermin
result
due
myriad
factor
fals
posit
andor
lack
specif
kit
design
etc
requir
either
retest
later
time
andor
molecular
test
nucleic
acid
cdcaphl
franc
differ
interpret
criteria
defin
posit
confirmatori
result
indic
lack
standard
defin
patient
posit
immun
respons
well
known
produc
antibodi
cross
react
wb
could
lead
fals
posit
result
lack
improv
advanc
wb
compar
antibodi
base
assay
nice
shown
masciotra
et
al
demonstr
rapid
hiv
test
actual
detect
antibodi
sever
day
earlier
wb
becom
posit
introduct
gener
antigenantibodi
test
allow
clinician
detect
reactiv
patient
earlier
diseas
cours
compar
gener
test
effect
narrow
window
serolog
detect
approxim
day
new
develop
clsi
aphl
recommend
new
algorithm
incorpor
antigenantibodi
combin
test
rapid
test
molecular
test
wb
test
obsolet
laboratori
adopt
newer
algorithm
hiv
test
addit
obsolet
test
test
may
inappropri
use
inappropri
util
includ
failur
follow
current
practic
guidelin
diagnosi
manag
diseas
thu
order
incorrect
test
panel
test
algorithm
test
order
test
frequent
lack
medic
rational
test
problem
resolut
need
reshap
way
improv
patient
outcom
lower
cost
acknowledg
laboratori
test
util
problem
known
publish
decad
studi
done
estim
document
percentag
unnecessari
test
typic
scenario
inappropri
test
order
occur
thyroid
function
test
diagnosi
manag
hypothyroid
guidelin
clear
appropri
test
thyroid
stimul
hormon
tsh
regard
best
screen
test
follow
free
thyroxin
free
tsh
abnorm
addit
test
often
order
includ
total
need
total
measur
free
provid
furthermor
ad
total
level
may
confus
diagnosi
chang
bind
protein
via
diseas
drug
therapi
result
total
inconsist
test
result
test
may
order
inappropri
time
wrong
test
order
vitamin
test
known
result
inappropri
erron
order
correct
test
routin
assess
vitamin
statu
defici
vitamin
test
vitamin
often
mistakenli
order
dihydroxi
form
vitamin
occasion
order
patient
kidney
diseas
decreas
level
one
earliest
chang
occur
person
earli
kidney
failur
howev
order
vitamin
simpli
erron
test
vitamin
unnecessari
assess
vitamin
statu
need
differenti
form
research
set
viral
cultur
tradit
gold
standard
virolog
detect
clinic
microbiolog
laboratori
direct
viral
detect
direct
patient
sampl
also
util
monoclon
antibodi
detect
viral
antigen
intent
obtain
result
timeli
manner
viral
cultur
molecular
technolog
becom
establish
clinic
microbiolog
laboratori
increas
sensit
specif
almost
alway
shorter
turnaroundtim
reason
ask
viral
cultur
one
exampl
molecular
test
help
answer
question
panel
develop
respiratori
virus
sever
commerci
compani
offer
version
rvp
respiratori
viru
panel
laboratori
offer
rvp
assay
detect
viral
target
result
obtain
sooner
tradit
virolog
test
molecular
rvp
offer
greater
sensit
specif
prior
direct
fluoresc
assay
dfa
sent
refer
laboratori
increas
sensit
rvp
allow
us
document
covir
infect
fulli
appreci
dfa
cultur
base
test
report
increas
sever
diseas
well
report
decreas
sever
diseas
set
covir
infect
much
research
must
done
understand
potenti
interact
differ
respiratori
virus
set
respiratori
infect
laboratori
publish
virogram
respiratori
viru
season
relat
viral
coinfect
fig
tabl
virogram
chart
respiratori
viru
preval
among
patient
popul
test
give
idea
circul
commun
anoth
exampl
molecular
test
replac
viral
cultur
detect
enteroviru
ev
csf
ev
pcr
shown
greater
sensit
cultur
studi
unpublish
perform
within
institut
look
util
inhous
ev
pcr
affect
length
stay
lo
cost
ev
pcr
neg
ev
pcr
posit
patient
ev
pcr
neg
result
averag
lo
day
greater
ev
pcr
posit
estim
addit
cost
relat
inpati
care
viral
cultur
still
import
grow
viru
purpos
subtyp
identifi
new
strain
antivir
test
howev
remain
specialti
research
lab
routin
clinic
diagnost
test
pcr
test
caus
agent
lyme
diseas
may
initi
make
sens
life
cycl
b
burgdorferi
pcr
detect
borrelia
dna
blood
less
half
patient
earli
acut
stage
diseas
characterist
erythema
migran
present
therefor
pcr
recommend
first
line
test
make
initi
diagnosi
lyme
diseas
review
articl
show
median
percent
sensit
pcr
test
blood
skin
biopsi
csf
synovi
fluid
respect
current
recommend
diagnost
test
involv
twotier
algorithm
approach
involv
antibodi
test
may
clinic
util
pcr
serolog
test
neg
inconclus
clinic
histori
symptom
strongli
suggest
lyme
diseas
hospit
introduc
outreach
program
market
laboratori
servic
physician
offic
nurs
home
hospit
increas
test
volum
reduc
unit
cost
per
test
effort
gener
increas
laboratori
test
util
monitor
averag
number
specif
test
order
per
subspeci
physician
per
month
tabl
data
collect
patient
requisit
process
day
access
area
outreach
specimen
receiv
area
sale
forc
introduc
outreach
administr
project
number
new
client
account
open
month
impact
laboratori
estim
multipli
volum
specif
test
per
physician
offic
practic
multipl
physician
volum
estim
util
test
per
laboratori
section
predict
futur
need
addit
analyz
andor
personnel
perform
laboratori
test
procedur
outreach
client
number
increas
util
data
vari
medic
subspeci
exampl
urolog
requisitionsphysician
proceduresrequisit
proceduresphysician
psa
highest
test
volum
compar
nurs
home
requisitionsphysician
proceduresrequisit
proceduresphysician
electrolyt
highest
test
volum
data
use
primarili
plan
best
strategi
absorb
increas
workload
new
client
bring
outreach
busi
also
use
monitor
use
obsolet
inappropri
lab
test
develop
educ
effort
improv
test
util
practic
subspeci
among
outreach
client
excel
review
laboratori
test
util
understand
mani
factor
involv
step
implement
chang
provid
recent
public
author
provid
insight
guidelin
assist
laboratori
initi
improv
laboratori
util
ultim
goal
includ
develop
adopt
moreeffect
test
algorithm
reduc
test
cost
use
new
technolog
costeffect
shorten
time
diagnosi
intervent
hospit
laboratori
focu
chang
physician
test
order
behavior
includ
elimin
obsolet
test
modifi
requisit
form
laboratori
alter
testrequisit
form
steer
clinician
right
direct
one
option
sight
mind
approach
certain
test
simpli
nt
appear
menu
assist
educ
promot
appropri
lab
test
part
hospit
continu
medic
educ
cme
program
clinician
grand
round
newslett
cme
lectur
reinforc
posit
chang
audit
clinician
use
new
protocol
offer
feedback
two
tier
review
process
molecular
send
test
use
tool
pathologist
learn
advic
wisdom
molecular
assay
final
hospit
implement
laboratori
util
formulari
committe
help
overse
test
promot
good
test
practic
similar
pharmaci
therapeut
committe
approach
met
great
success
use
molecular
method
respiratori
viru
test
allow
us
detect
patient
viru
present
presenc
multipl
virus
within
patient
sampl
current
underappreci
effect
overal
diseas
present
current
unknown
